quinazolines has been researched along with calpain in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carpenter, G; Liao, HJ | 1 |
Bao, L; Cao, Q; Chen, K; Huang, X; Li, X; Liu, L; Lou, N; Qiu, B; Ruan, H; Wang, K; Xiao, W; Xu, G; Yang, H; Yuan, C; Zhang, X | 1 |
Bai, C; Chang, M; Fang, T; Hong, Q; Li, J; Zhang, G; Zhou, J | 1 |
3 other study(ies) available for quinazolines and calpain
Article | Year |
---|---|
Regulated intramembrane cleavage of the EGF receptor.
Topics: Amyloid Precursor Protein Secretases; Calpain; Cell Line, Tumor; Cell Membrane; Cell Nucleus; Epidermal Growth Factor; ErbB Receptors; Gene Expression; Glycoproteins; HEK293 Cells; Humans; Ionomycin; Proteolysis; Quinazolines; Serine Endopeptidases; Serine Proteinase Inhibitors; Tyrphostins | 2012 |
Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells.
Topics: Androgens; Calpain; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Quinazolines; Receptors, Androgen; Signal Transduction; Taxoids | 2017 |
Calpain 2 knockdown promotes cell apoptosis and restores gefitinib sensitivity through epidermal growth factor receptor/protein kinase B/survivin signaling.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Calpain; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Survivin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |